Globally, cervical cytology continues to serve as the cornerstone of cervical cancer screening programs, but WHO 2021 guidelines advocate HPV DNA testing as the primary screening modality due to its… Click to show full abstract
Globally, cervical cytology continues to serve as the cornerstone of cervical cancer screening programs, but WHO 2021 guidelines advocate HPV DNA testing as the primary screening modality due to its heightened sensitivity. This method necessitates additional triage with cytology or colposcopy to detect precancerous lesions. Hormonal shifts and anatomical alterations in postmenopausal women may impact diagnostic outcomes in either modality.
Keywords:
triage;
postmenopausal women;
cervical cancer;
cancer screening;
cytology
Journal Title: Diagnostic Cytopathology
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diagnostic Cytopathology
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!